Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr;476(4):689-701.
doi: 10.1007/s00424-024-02918-z. Epub 2024 Feb 9.

Acid-base transporters in the context of tumor heterogeneity

Affiliations
Review

Acid-base transporters in the context of tumor heterogeneity

Stine Helene Falsig Pedersen. Pflugers Arch. 2024 Apr.

Abstract

The copious metabolic acid production and -extrusion by cancer cells render poorly vascularized regions of solid tumors highly acidic. A growing list of proton - and bicarbonate transporters has been suggested to contribute to net acid extrusion from cancer cells, and/or been shown to be dysregulated and favor malignant development in various cancers. The great majority of these roles have been studied at the level of the cancer cells. However, recent advances in understanding of the cellular and physicochemical heterogeneity of solid tumors both enable and necessitate a reexamination of the regulation and roles of acid-base transporters in such malignancies. This review will briefly summarize the state-of-the-art, with a focus on the SLC9A and SLC4A families, for which most evidence is available. This is followed by a discussion of key concepts and open questions arising from recent insights and of the challenges that need to be tackled to address them. Finally, opportunities and challenges in therapeutic targeting of the acid-base transportome in cancers will be addressed.

Keywords: Acid–base regulation; SLC4A4; SLC4A7; SLC9A1; Tumor heterogeneity; Tumor microenvironment.

PubMed Disclaimer

Similar articles

Cited by

  • The mighty proton.
    Wagner CA, Silva PHI. Wagner CA, et al. Pflugers Arch. 2024 Apr;476(4):423-425. doi: 10.1007/s00424-024-02942-z. Epub 2024 Mar 9. Pflugers Arch. 2024. PMID: 38460007 No abstract available.

References

    1. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, Eccles D, Evans DG, Fletcher O, Johnson N et al (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41:585–590 - PubMed - PMC - DOI
    1. Amith SR, Wilkinson JM, Baksh S, Fliegel L (2015) The Na+/H+ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells. Oncotarget 6:1262–1275. https://doi.org/10.18632/oncotarget.2860 - DOI - PubMed
    1. Andersen AP, Flinck M, Oernbo EK, Pedersen NB, Viuff BM, Pedersen SF (2016) Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment. Mol Cancer 15:45. https://doi.org/10.1186/s12943-016-0528-0 - DOI - PubMed - PMC
    1. Andersen AP, Samsøe-Petersen J, Oernbo EK, Boedtkjer E, Moreira JMA, Kveiborg M, Pedersen SF (2018) The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms. Int J Cancer 142:2529–2542. https://doi.org/10.1002/ijc.31276 - DOI - PubMed
    1. Boedtkjer E, Bentzon JF, Dam VS, Aalkjaer C (2016) Na+, HCO3–cotransporter NBCn1 increases pHi gradients, filopodia, and migration of smooth muscle cells and promotes arterial remodelling. CardiovascRes 111:227–239 - DOI

LinkOut - more resources